Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxindanshen Dropping Pills for depression or anxiety after PCI in coronary heart disease
ChiCTR1900023457Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Mar 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Guanxin Danshen Dripping Pills in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: PHQ-9 scale, GAD-7 scale and 1 more. Started Mar 2017; status: recruiting.
02
Drugs
Guanxin Danshen Dripping Pills
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on ChiCTR1900023457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023457.